Thursday, July 28, 2016

Novadaq Q2 revenue climbs 34%

Novadaq Q2 revenue climbs 34%

July 27, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) reported revenue of $20.1-million in the second quarter, an increase of 34% from $15.1-million a year ago. Total direct sales in the latest quarter increased by $4.4-million, or 37%, and total partnered/international sales rose by $600,000, or 21%, compared with the same period last year. The company estimates that the number […]

Avivagen, UNAHCO register OxC-beta in Philippines

Avivagen, UNAHCO register OxC-beta in Philippines

July 27, 2016 by · Leave a Comment 

Tweet Avivagen (TSX-V:VIV) and UNAHCO have registered OxC-beta Livestock as an imported livestock feed additive, authorizing its use in all species in the Philippines. UNAHCO is a feed and veterinary unit of Unilab, the largest pharmaceutical company in the Philippines. UNAHCO provides a broad range of animal healthcare and nutrition products and programs to meet […]

ProMIS names Johanne Kaplan as CDO

ProMIS names Johanne Kaplan as CDO

July 21, 2016 by · Leave a Comment 

Tweet ProMIS Neurosciences (TSX:PMN) has appointed Johanne Kaplan to the post of chief development officer to focus on supporting the design and execution of the company’s development programs and partnering efforts. Dr. Kaplan joins ProMIS following 24 years at Genzyme, where she held positions of increasing responsibility, culminating in her decade-long tenure as VP of […]

ProMIS in new program to identify ALS targets

ProMIS in new program to identify ALS targets

July 19, 2016 by · Leave a Comment 

Tweet ProMIS Neurosciences (TSX:PMN) has initiated a program to identify novel therapeutic targets on neurotoxic strains of the protein TDP43, which is implicated in the development of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). “ProMIS will apply its proprietary computational algorithms, supplemented by other methods pioneered by ProMIS scientists, to identify specific therapeutic targets […]

ProMIS announces new AZ program

ProMIS announces new AZ program

July 14, 2016 by · Leave a Comment 

Tweet ProMIS Neurosciences (TSX:PMN) has initiated a program to identify novel therapeutic targets on neurotoxic strains of the protein tau, which, like neurotoxic strains of Amyloid beta (Ab), are implicated in the development of Alzheimer’s disease (AD). “With multiple product candidates in our Ab program progressing to final validation and selection for drug development, we […]

Novadaq announces CEO change

Novadaq announces CEO change

July 6, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has appointed Dr. Rick Mangat as president and CEO, succeeding Arun Menawat, who has resigned as president, CEO and chairman, to pursue new opportunities and interests. In addition, Bill MacKinnon, former CEO of KPMG Canada and head of the Novadaq’s audit committee, has been appointed chairman. Dr. Mangat is a […]

Merus Labs moving up the value chain

Merus Labs moving up the value chain

July 5, 2016 by · Leave a Comment 

Tweet After an 18-month company transformation under new CEO, Barry Fishman, Merus Labs International (NASDAQ:MSLI; TSX:MSL) is now ready to in-license new pharmaceutical products, in addition to optimizing existing products and continuing to acquire legacy products that are no longer strategic for major pharmaceutical companies. “Since the fall of 2014, we’ve strengthened the management team […]

Merus Labs appoints two senior executives

Merus Labs appoints two senior executives

July 3, 2016 by · Leave a Comment 

Tweet Merus Labs International (NASDAQ:MSLI; TSX:MSL) has appointed two key additions to its executive leadership team, effective July 1. Dr. Michael Bumby was named CFO, succeeding Andrew Patient, who has decided to leave the company to pursue other opportunities. Mr. Patient will remain with Merus Labs for a period of time to ensure a smooth […]

Titan Medical CEO resigns as director following AGM vote

Titan Medical CEO resigns as director following AGM vote

June 23, 2016 by · Leave a Comment 

Tweet At the annual meeting of Titan Medical (TSX:TMD), shareholders voted against reelecting John Hargrove, CEO and chairman, as a director. Mr. Hargrove received 42% of votes cast in favor of reelection and 58% against. Following the meeting, Mr. Hargrove tendered his resignation as a director of Titan Medical in accordance with the company’s majority […]

Avivagen reports new livestock trials with OxC-beta

Avivagen reports new livestock trials with OxC-beta

June 20, 2016 by · Leave a Comment 

Tweet Avivagen (TSX-V:VIV) has provided results of four new trials of OxC-beta livestock as a feed additive for swine in the Philippines and Vietnam, and broiler poultry in the Philippines and Spain. In a new trial with the National Institute of Animal Sciences for Vietnam, the use of OxC-beta significantly improved the major commercial parameters […]

Next Page »

Email Newsletters with Constant Contact
Google+